SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694665-22-000021
Filing Date
2022-01-21
Accepted
2022-01-21 16:58:36
Documents
1
Period of Report
2022-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164280229342416.html 4  
1 FORM 4 wf-form4_164280229342416.xml 4 3962
  Complete submission text file 0001694665-22-000021.txt   5465
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address
Plinio Mark D. (Reporting) CIK: 0001865558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 22546623